glp 1 weight regain What Comes Back When Stopping GLP-1s? GLP-1 Discontinuation Results in Significant

ESC, European society of cardiology

GLP-1/GIP is a dual-action treatment that works as both a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, helping to control blood sugar and support weight loss

Additionally, their potential anti-inflammatory properties mediated by inhibition of key signaling pathways, could align well with the immunopathogenesis of PsD, as suggested by preclinical and clinical evidence supporting their broader immunomodulatory across a spectrum of rheumatological and dermatological conditions

They aim to enhance weight loss, often ranging from 10% to 30% total body weight loss, and reduce liver fibrosis in MASH

Gestational diabetes mellitus management with oral hypoglycemic agents

How can I discuss combination approaches with my provider